EUVIMEDEUVIMED entdecken
Crossref

Understanding dermatophytosis ( Qūbā ) in Unani medicine: Classical descriptions and evidence from recent clinical studies

Nazim Husain, Abrar Alam, Sumayya Tasneem Parapur, Abdul Khalique, Usama Akram, Younis Iftikhar Munshi

Traditional Medicine and Modern Medicine · 2026-01 · 09

DOI: 10.1142/s2575900026300079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Traditional Medicine and Modern Medicine, online erschienen am 29.07.2026. Verfasst von Nazim Husain und 5 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dermatophytosis (tinea), described as Qūbā in Unani medicine, remains a common superficial fungal infection with a significant global burden. Rising antifungal resistance, frequent relapses, and treatment failures have prompted exploration of complementary therapeutic systems such as Unani medicine and other Ayush systems.

Objective

The objective of this narrative review is to synthesize classical Unani perspectives on Qūbā with insights from modern clinical literature on dermatophytosis, and to contextualize the therapeutic potential and emerging clinical outcomes of Unani formulations in dermatophytosis management.

Methods

Classical Unani texts by Ibn Sı̄nā, Rāzı̄, Jurjānı̄, and others were critically reviewed to extract concepts related to etiology, classification, and treatment of Qūbā. A targeted database search (PubMed, ScienceDirect, Google Scholar) identified randomized clinical trials, observational studies, and case reports assessing the efficacy and safety of Unani interventions.

Results

Unani literature attributes Qūbā to morbid Sawdā accumulation and emphasizes humoral correction through Tanqiya (purification), Taḥlı̄l (resolution), and topical applications. Modern clinical studies involving Majūn Ushbā, Marham Rāl, Marham Khārish Jadı̄d, vinegar-based polyherbal pastes, and herbal antimicrobial soaps report symptom reduction and early mycological clearance, in some cases suggesting potential non-inferiority to terbinafine and fluconazole in limited cohorts. Improvement within 4–8 weeks and favorable tolerability were commonly observed, though follow-up duration and adverse event reporting were often limited.

Conclusion

Unani medicine presents a holistic, culturally aligned therapeutic system for dermatophytosis, with promising preliminary clinical outcomes. However, to move beyond exploratory evidence, larger, rigorously designed multicentric trials, standardized pharmacognostic profiling, mechanistic validation, and structured safety monitoring are required to define its role within evidence-based integrative dermatology.

Zitieren

APA

Husain, N., Alam, A., Parapur, S. T., Khalique, A., Akram, U., & Munshi, Y. I. (2026). Understanding dermatophytosis ( Qūbā ) in Unani medicine: Classical descriptions and evidence from recent clinical studies. Traditional Medicine and Modern Medicine, 09. https://doi.org/10.1142/s2575900026300079

Vancouver

Husain N, Alam A, Parapur ST, Khalique A, Akram U, Munshi YI. Understanding dermatophytosis ( Qūbā ) in Unani medicine: Classical descriptions and evidence from recent clinical studies. Traditional Medicine and Modern Medicine. 2026;09. doi:10.1142/s2575900026300079

BibTeX
@article{Husain2026,
  author = {Husain, Nazim and Alam, Abrar and Parapur, Sumayya Tasneem and Khalique, Abdul and Akram, Usama and Munshi, Younis Iftikhar},
  title = {Understanding dermatophytosis ( Qūbā ) in Unani medicine: Classical descriptions and evidence from recent clinical studies},
  journal = {Traditional Medicine and Modern Medicine},
  year = {2026},
  volume = {09},
  doi = {10.1142/s2575900026300079}
}
Kostenlos starten →